Cervical Cancer Mortality Among US Women Younger Than 25 Years, 1992-2021
Cette étude analyse les tendances récentes de la mortalité par cancer du col de l'utérus chez les Américaines de moins de 25 ans
Human papillomavirus (HPV) vaccination has been recommended for routine use in US women since June 2006. Studies from 2022 and 2023 indicated a 12% per year decline (overall, 65% reduction) in cervical cancer incidence during 2012 to 2019 among US women younger than 25 years who likely benefited from HPV vaccination. Because a reduction in mortality follows a reduction in incidence, we evaluated recent trends in cervical cancer mortality among young women.